Impact on survival of high-dose therapy with autologous stem cell support in patients younger than 60 years with newly diagnosed multiple myeloma: a population-based study. Nordic Myeloma Study Group (Q47692265)
Jump to navigation
Jump to search
scientific article published in January 2000
Language | Label | Description | Also known as |
---|---|---|---|
English | Impact on survival of high-dose therapy with autologous stem cell support in patients younger than 60 years with newly diagnosed multiple myeloma: a population-based study. Nordic Myeloma Study Group |
scientific article published in January 2000 |
Statements
1 reference
Impact on survival of high-dose therapy with autologous stem cell support in patients younger than 60 years with newly diagnosed multiple myeloma: a population-based study. Nordic Myeloma Study Group (English)
1 reference
1 reference
Johnsen HE
1 reference
Lenhoff S
1 reference
Hjorth M
1 reference
Turesson I
1 reference
Westin J
1 reference
Nielsen JL
1 reference
Wislöff F
1 reference
Brinch L
1 reference
Carlson K
1 reference
Carlsson M
1 reference
Dahl IM
1 reference
Gimsing P
1 reference
Hippe E
1 reference
Lamvik J
1 reference
Löfvenberg E
1 reference
Nesthus I
1 reference
Rödjer S
1 reference
1 January 2000
1 reference
1 reference
95
1 reference
1
1 reference
7-11
1 reference